FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF, 2
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
Molecular analysis in two Tunisian families with combined factor V and factor VIII deficiency.
|
20491958 |
2010 |
FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF, 2
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
The first case of combined coagulation factor V and coagulation factor VIII deficiency in Poland due to a novel p.Tyr135Asn missense mutation in the MCFD2 gene.
|
18685427 |
2008 |
FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF, 2
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
New insights into multiple coagulation factor deficiency from the solution structure of human MCFD2.
|
18590741 |
2008 |
FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF, 2
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Combined deficiency of factor V and factor VIII is due to mutations in either LMAN1 or MCFD2.
|
16304051 |
2006 |
FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF, 2
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
Bleeding due to disruption of a cargo-specific ER-to-Golgi transport complex.
|
12717434 |
2003 |
FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF, 2
|
0.700 |
Biomarker
|
disease |
CTD_human |
|
|
|
FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF, 2
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Familial Multiple Coagulation Factor Deficiency I
|
0.400 |
GeneticVariation
|
disease |
CLINVAR |
Diagnostic high-throughput sequencing of 2396 patients with bleeding, thrombotic, and platelet disorders.
|
31064749 |
2019 |
Familial Multiple Coagulation Factor Deficiency I
|
0.400 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Combined deficiency of factor V and factor VIII is due to mutations in either LMAN1 or MCFD2.
|
16304051 |
2006 |
FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF
|
0.380 |
Biomarker
|
disease |
BEFREE |
On the contrary, thrombin generation in F5F8D platelet-rich plasma (PRP) was significantly lower than in normal controls (P < .05); however, it was fully corrected by normalizing FVIII or after 1-deamino-8-d-arginine vasopressin (DDAVP) infusion, indicating that the hypocoagulable state of F5F8D patients is associated with low FVIII levels.
|
31558466 |
2019 |
FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF
|
0.380 |
GeneticVariation
|
disease |
BEFREE |
We used PCI to treat the coronary artery disease in a patient with the combined deficiency of factor V and factor VIII (F5F8D) and analysed the molecular basis of the disorder for this patient.
|
23557496 |
2013 |
FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF
|
0.380 |
Biomarker
|
disease |
BEFREE |
Crystal structure of the LMAN1-CRD/MCFD2 transport receptor complex provides insight into combined deficiency of factor V and factor VIII.
|
20138881 |
2010 |
FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF
|
0.380 |
GeneticVariation
|
disease |
BEFREE |
Measurement of platelet factor V (FV) levels in 7 F5F8D patients (4 with LMAN1 and 3 with MCFD2 mutations) demonstrated similar reductions to those observed for plasma FV.
|
18391077 |
2008 |
FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF
|
0.380 |
AlteredExpression
|
disease |
BEFREE |
Surface plasmon resonance experiments demonstrated that MCFD2 specifically bound to sERGIC-53 and 2 MCFD2 mutants found in F5F8D patients had a K(a) that was 3 or 4 orders of magnitude lower for sERGIC-53 than for wild-type MCFD2.
|
18056485 |
2008 |
FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF
|
0.380 |
GeneticVariation
|
disease |
BEFREE |
Here, we studied a F5F8D patient who was found to be a compound heterozygote for 2 novel mutations in MCFD2: a large deletion of 8.4 kb eliminating the 5'UTR of the gene and a nonsense mutation resulting in the deletion of only 3 amino acids (DeltaSLQ) from the C-terminus of MCFD2.
|
17971482 |
2008 |
FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF
|
0.380 |
GermlineCausalMutation
|
disease |
ORPHANET |
Combined deficiency of factor V and factor VIII is due to mutations in either LMAN1 or MCFD2.
|
16304051 |
2006 |
FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF
|
0.380 |
GeneticVariation
|
disease |
BEFREE |
Mutations in LMAN1 (ERGIC-53) or MCFD2 cause combined deficiency of factor V and factor VIII (F5F8D).
|
16304051 |
2006 |
FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF
|
0.380 |
GermlineCausalMutation
|
disease |
ORPHANET |
Mutations in LMAN1 (also called ERGIC-53) result in combined deficiency of factor V and factor VIII (F5F8D), an autosomal recessive bleeding disorder characterized by coordinate reduction of both clotting proteins.
|
12717434 |
2003 |
FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF
|
0.380 |
GeneticVariation
|
disease |
BEFREE |
Mutations in LMAN1 (also called ERGIC-53) result in combined deficiency of factor V and factor VIII (F5F8D), an autosomal recessive bleeding disorder characterized by coordinate reduction of both clotting proteins.
|
12717434 |
2003 |
Transient Ischemic Attack
|
0.200 |
Biomarker
|
disease |
RGD |
Mutations in the MCFD2 gene are predominant among patients with hereditary combined FV and FVIII deficiency (F5F8D) in India.
|
17610559 |
2007 |
Epistaxis
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Menorrhagia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Persistent bleeding after trauma
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Reduced factor VIII activity
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Factor V deficiency
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|